| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.881 | 0.001 | 0.897 | RNA-directed DNA polymerase inhibitor | 0.802 0.002 DBMET01173 0.848 0.001 DBMET01174 0.897 0.001 DBMET01175 | DBMET01175 | |
| 0.729 | 0.004 | 0.729 | DNA synthesis inhibitor | 0.543 0.01 DBMET01173 0.622 0.007 DBMET01174 0.68 0.005 DBMET01175 | ||
| 0.627 | 0.009 | 0.75 | Immunomodulator | 0.75 0.005 DBMET01173 0.667 0.007 DBMET01174 0.657 0.007 DBMET01175 | DBMET01173 | |
| 0.612 | 0.015 | 0.621 | Immunostimulant | 0.569 0.02 DBMET01173 0.621 0.014 DBMET01174 0.598 0.017 DBMET01175 | DBMET01174 | |
| 0.64 | 0.046 | 0.896 | DNA directed DNA polymerase inhibitor | 0.569 0.064 DBMET01173 0.82 0.016 DBMET01174 0.896 0.008 DBMET01175 | DBMET01175 | |
| 0.436 | 0.005 | 0.808 | DNA polymerase I inhibitor | 0.564 0.003 DBMET01173 0.772 0.001 DBMET01174 0.808 0.001 DBMET01175 | DBMET01175 | |
| 0.334 | 0.006 | 0.818 | DNA directed RNA polymerase inhibitor | 0.498 0.004 DBMET01173 0.753 0.003 DBMET01174 0.818 0.003 DBMET01175 | DBMET01175 | |
| 0.335 | 0.01 | 0.713 | Adenylate cyclase inhibitor | 0.614 0.004 DBMET01173 0.687 0.002 DBMET01174 0.713 0.001 DBMET01175 | DBMET01175 | |
| 0.389 | 0.068 | 0.507 | Immunosuppressant | 0.507 0.031 DBMET01173 0.469 0.042 DBMET01174 0.444 0.049 DBMET01175 | DBMET01173 | |
| 0.383 | 0.061 | 0.502 | Vasodilator, peripheral | 0.374 0.064 DBMET01173 0.423 0.048 DBMET01174 0.502 0.027 DBMET01175 | DBMET01175 | |
| 0.32 | 0.002 | 0.327 | Antiviral (Hepatitis D) | 0.289 0.002 DBMET01173 0.283 0.002 DBMET01174 0.327 0.002 DBMET01175 | DBMET01175 | |
| 0.285 | 0.025 | 0.285 | Diuretic | |||
| 0.271 | 0.021 | 0.549 | Bone formation stimulant | 0.549 0.004 DBMET01173 0.498 0.005 DBMET01174 0.474 0.007 DBMET01175 | DBMET01173 | |
| 0.254 | 0.041 | 0.356 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.286 0.028 DBMET01173 0.356 0.012 DBMET01174 0.354 0.012 DBMET01175 | DBMET01174 | |
| 0.213 | 0.025 | 0.213 | Cell wall synthesis inhibitor | |||
| 0.186 | 0.009 | 0.186 | Transcription factor STAT6 inhibitor | 0.118 0.063 DBMET01173 0.116 0.068 DBMET01174 | ||
| 0.184 | 0.008 | 0.676 | Carbamoyl phosphate synthetase inhibitor | 0.529 0.002 DBMET01173 0.646 0.001 DBMET01174 0.676 0.001 DBMET01175 | DBMET01175 | |
| 0.178 | 0.019 | 0.423 | Adenylate kinase inhibitor | 0.316 0.006 DBMET01173 0.391 0.003 DBMET01174 0.423 0.003 DBMET01175 | DBMET01175 | |
| 0.27 | 0.115 | 0.353 | Vasodilator, coronary | 0.31 0.079 DBMET01173 0.309 0.08 DBMET01174 0.353 0.054 DBMET01175 | DBMET01175 | |
| 0.155 | 0.005 | 0.404 | Purinergic P2Y antagonist | 0.129 0.006 DBMET01173 0.333 0.003 DBMET01174 0.404 0.002 DBMET01175 | DBMET01175 | |
| 0.137 | 0.004 | 0.137 | Squalene synthetase inhibitor | 0.095 0.007 DBMET01173 0.093 0.007 DBMET01174 0.086 0.007 DBMET01175 | ||
| 0.148 | 0.018 | 0.547 | NADH dehydrogenase inhibitor | 0.432 0.004 DBMET01173 0.547 0.003 DBMET01174 0.546 0.003 DBMET01175 | DBMET01174 | |
| 0.301 | 0.172 | 0.301 | Apoptosis agonist | |||
| 0.134 | 0.011 | 0.233 | Acyl-CoA dehydrogenase inhibitor | 0.211 0.005 DBMET01173 0.233 0.004 DBMET01174 0.233 0.004 DBMET01175 | DBMET01175 | |
| 0.124 | 0.002 | 0.411 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.277 0 DBMET01173 0.32 0 DBMET01174 0.411 0 DBMET01175 | DBMET01175 | |
| 0.219 | 0.113 | 0.219 | Transcription factor STAT inhibitor | |||
| 0.105 | 0.004 | 0.321 | Fructose-1,6-bisphosphatase inhibitor | 0.321 0.002 DBMET01173 0.185 0.003 DBMET01174 0.129 0.003 DBMET01175 | DBMET01173 | |
| 0.096 | 0.005 | 0.385 | Purinergic P2T antagonist | 0.036 0.011 DBMET01173 0.279 0.004 DBMET01174 0.385 0.003 DBMET01175 | DBMET01175 | |
| 0.203 | 0.113 | 0.203 | DNA damaging | |||
| 0.093 | 0.004 | 0.278 | Cytokine production stimulant | 0.278 0.001 DBMET01173 0.162 0.002 DBMET01174 0.137 0.003 DBMET01175 | DBMET01173 | |
| 0.227 | 0.149 | 0.227 | Apoptosis antagonist | |||
| 0.083 | 0.004 | 0.142 | Geranyltranstransferase inhibitor | 0.086 0.004 DBMET01173 0.142 0.002 DBMET01174 0.14 0.002 DBMET01175 | DBMET01174 | |
| 0.244 | 0.182 | 0.244 | Antibacterial | |||
| 0.064 | 0.004 | 0.064 | Elastase 2 inhibitor | |||
| 0.064 | 0.004 | 0.064 | Elastase 2A inhibitor | |||
| 0.09 | 0.035 | 0.272 | Purinergic P2X2 antagonist | 0.179 0.007 DBMET01173 0.235 0.003 DBMET01174 0.272 0.002 DBMET01175 | DBMET01175 | |
| 0.171 | 0.117 | 0.171 | Hypolipemic | |||
| 0.057 | 0.008 | 0.371 | Purinergic P2X agonist | 0.098 0.003 DBMET01173 0.266 0.001 DBMET01174 0.371 0.001 DBMET01175 | DBMET01175 | |
| 0.071 | 0.031 | 0.263 | Biliverdin reductase inhibitor | 0.215 0.005 DBMET01173 0.263 0.004 DBMET01174 0.262 0.004 DBMET01175 | DBMET01174 | |
| 0.101 | 0.064 | 0.173 | Folate antagonist | 0.166 0.017 DBMET01173 0.173 0.015 DBMET01174 0.158 0.019 DBMET01175 | DBMET01174 | |
| 0.055 | 0.026 | 0.102 | Adenosine deaminase inhibitor | 0.097 0.006 DBMET01173 0.102 0.005 DBMET01174 0.099 0.005 DBMET01175 | DBMET01174 | |
| 0.038 | 0.01 | 0.038 | Elastase 2B inhibitor | |||
| 0.038 | 0.01 | 0.038 | Elastase 3B inhibitor | |||
| 0.038 | 0.01 | 0.038 | Elastase 3A inhibitor | |||
| 0.088 | 0.063 | 0.48 | Aminoacyl-tRNA synthetase inhibitor | 0.172 0.014 DBMET01173 0.393 0.004 DBMET01174 0.48 0.003 DBMET01175 | DBMET01175 | |
| 0.026 | 0.003 | 0.534 | Purine nucleoside phosphorylase inhibitor | 0.534 0.001 DBMET01173 0.497 0.001 DBMET01174 0.475 0.001 DBMET01175 | DBMET01173 | |
| 0.059 | 0.036 | 0.317 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.189 0.007 DBMET01173 0.278 0.004 DBMET01174 0.317 0.003 DBMET01175 | DBMET01175 | |
| 0.032 | 0.011 | 0.2 | Purinergic P2Y12 antagonist | 0.021 0.018 DBMET01173 0.094 0.004 DBMET01174 0.2 0.004 DBMET01175 | DBMET01175 | |
| 0.029 | 0.009 | 0.088 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.073 0.003 DBMET01173 0.081 0.003 DBMET01174 0.088 0.003 DBMET01175 | DBMET01175 | |
| 0.029 | 0.009 | 0.253 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.253 0.001 DBMET01173 0.127 0.002 DBMET01174 0.08 0.003 DBMET01175 | DBMET01173 | |
| 0.023 | 0.006 | 0.076 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.076 0.004 DBMET01173 0.028 0.005 DBMET01174 0.024 0.005 DBMET01175 | DBMET01173 | |
| 0.021 | 0.007 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.026 0.003 DBMET01173 0.029 0.003 DBMET01174 0.029 0.003 DBMET01175 | DBMET01175 | |
| 0.081 | 0.067 | 0.081 | Vanilloid agonist | |||
| 0.04 | 0.03 | 0.235 | Thymidine kinase inhibitor | 0.103 0.006 DBMET01173 0.18 0.003 DBMET01174 0.235 0.002 DBMET01175 | DBMET01175 | |
| 0.018 | 0.01 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 DBMET01173 | ||
| 0.056 | 0.049 | 0.266 | Purinergic P2X1 antagonist | 0.167 0.005 DBMET01173 0.237 0.002 DBMET01174 0.266 0.002 DBMET01175 | DBMET01175 | |
| 0.048 | 0.042 | 0.334 | Ornithine carbamoyltransferase inhibitor | 0.156 0.009 DBMET01173 0.259 0.005 DBMET01174 0.334 0.004 DBMET01175 | DBMET01175 | |
| 0.061 | 0.056 | 0.274 | Phosphofructokinase-1 inhibitor | 0.161 0.016 DBMET01173 0.232 0.009 DBMET01174 0.274 0.006 DBMET01175 | DBMET01175 | |
| 0.025 | 0.021 | 0.187 | Thymidine phosphorylase inhibitor | 0.187 0.002 DBMET01173 0.096 0.003 DBMET01174 0.067 0.004 DBMET01175 | DBMET01173 | |
| 0.066 | 0.063 | 0.087 | Phosphodiesterase VIII inhibitor | 0.087 0.025 DBMET01173 0.068 0.059 DBMET01174 | DBMET01173 | |
| 0.014 | 0.013 | 0.108 | Purinergic P2Y1 agonist | 0.039 0.003 DBMET01173 0.083 0.001 DBMET01174 0.108 0.001 DBMET01175 | DBMET01175 | |
| 0.014 | 0.014 | 0.084 | Purinergic P2Y1 antagonist | 0.028 0.005 DBMET01173 0.072 0.003 DBMET01174 0.084 0.003 DBMET01175 | DBMET01175 | |
| 0.059 | 0.06 | 0.641 | HIV-1 reverse transcriptase inhibitor | 0.173 0.012 DBMET01173 0.565 0.004 DBMET01174 0.641 0.003 DBMET01175 | DBMET01175 | |
| 0.02 | 0.022 | 0.029 | Adenosine A1 receptor agonist | 0.029 0.012 DBMET01173 0.027 0.014 DBMET01174 0.025 0.016 DBMET01175 | DBMET01173 | |
| 0.04 | 0.042 | 0.061 | Farnesyltransferase inhibitor | 0.058 0.021 DBMET01174 0.061 0.019 DBMET01175 | DBMET01175 | |
| 0.005 | 0.009 | 0.007 | DNA polymerase III subunit alpha inhibitor | 0.007 0.004 DBMET01173 | DBMET01173 | |
| 0.068 | 0.076 | 0.164 | Interferon agonist | 0.164 0.009 DBMET01173 0.12 0.017 DBMET01174 0.096 0.032 DBMET01175 | DBMET01173 | |
| 0.009 | 0.018 | 0.159 | Purinergic receptor agonist | 0.018 0.008 DBMET01173 0.088 0.002 DBMET01174 0.159 0.001 DBMET01175 | DBMET01175 | |
| 0.009 | 0.018 | 0.159 | Purinergic P2 agonist | 0.018 0.008 DBMET01173 0.088 0.002 DBMET01174 0.159 0.001 DBMET01175 | DBMET01175 | |
| 0.137 | 0.146 | 0.152 | Anticonvulsant | 0.152 0.126 DBMET01173 | DBMET01173 | |
| 0.141 | 0.15 | 0.223 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.223 0.056 DBMET01173 0.191 0.082 DBMET01174 0.163 0.115 DBMET01175 | DBMET01173 | |
| 0.011 | 0.02 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.011 DBMET01173 | DBMET01173 | |
| 0.036 | 0.046 | 0.112 | Antimetabolite | 0.042 0.038 DBMET01173 0.093 0.017 DBMET01174 0.112 0.015 DBMET01175 | DBMET01175 | |
| 0.007 | 0.019 | 0.14 | Purinergic P2Y agonist | 0.013 0.009 DBMET01173 0.075 0.002 DBMET01174 0.14 0.001 DBMET01175 | DBMET01175 | |
| 0.013 | 0.025 | 0.016 | Adenosine A3 receptor agonist | 0.016 0.014 DBMET01173 | DBMET01173 | |
| 0.026 | 0.039 | 0.324 | Phosphoglycerate kinase inhibitor | 0.151 0.004 DBMET01173 0.259 0.003 DBMET01174 0.324 0.002 DBMET01175 | DBMET01175 | |
| 0.063 | 0.082 | 0.111 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.111 0.029 DBMET01173 | DBMET01173 | |
| 0.146 | 0.168 | 0.171 | MAP kinase kinase 5 inhibitor | 0.171 0.082 DBMET01173 | DBMET01173 | |
| 0.031 | 0.063 | 0.07 | Ribonucleotide reductase inhibitor | 0.053 0.04 DBMET01174 0.07 0.031 DBMET01175 | DBMET01175 | |
| 0.079 | 0.114 | 0.309 | c-Src kinase inhibitor | 0.304 0.017 DBMET01173 0.309 0.016 DBMET01174 0.29 0.019 DBMET01175 | DBMET01174 | |
| 0.054 | 0.091 | 0.256 | Glutamate dehydrogenase inhibitor | 0.127 0.021 DBMET01173 0.2 0.01 DBMET01174 0.256 0.007 DBMET01175 | DBMET01175 | |
| 0.05 | 0.087 | 0.092 | Interferon inducer | 0.092 0.016 DBMET01173 | DBMET01173 | |
| 0.059 | 0.103 | 0.096 | ErbB-3 antagonist | 0.096 0.044 DBMET01173 | DBMET01173 | |
| 0 | 0.045 | 0.022 | Purinergic P2Y4 agonist | 0.009 0.002 DBMET01174 0.022 0.001 DBMET01175 | DBMET01175 | |
| 0.022 | 0.068 | 0.052 | Purinergic P2X3 antagonist | 0.035 0.022 DBMET01174 0.052 0.01 DBMET01175 | DBMET01175 | |
| 0.032 | 0.085 | 0.208 | Argininosuccinate synthase inhibitor | 0.091 0.021 DBMET01173 0.164 0.01 DBMET01174 0.208 0.007 DBMET01175 | DBMET01175 | |
| 0.017 | 0.071 | 0.099 | Fumarate hydratase inhibitor | 0.043 0.017 DBMET01173 0.073 0.008 DBMET01174 0.099 0.005 DBMET01175 | DBMET01175 | |
| 0.036 | 0.093 | 0.296 | Purinergic P2 antagonist | 0.225 0.005 DBMET01174 0.296 0.005 DBMET01175 | DBMET01175 | |
| 0.13 | 0.189 | 0.162 | Vasodilator | 0.162 0.141 DBMET01175 | DBMET01175 | |
| 0.141 | 0.208 | 0.2 | ErbB-1 antagonist | 0.2 0.089 DBMET01173 | DBMET01173 | |
| 0.015 | 0.092 | 0.037 | Purinergic P2Y15 antagonist | 0.037 0.009 DBMET01173 | DBMET01173 | |
| 0.04 | 0.119 | 0.102 | CDK2/cyclin E2 inhibitor | 0.102 0.027 DBMET01173 | DBMET01173 | |
| 0.007 | 0.089 | 0.112 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.091 0.003 DBMET01173 0.112 0.003 DBMET01174 0.11 0.003 DBMET01175 | DBMET01174 | |
| 0.071 | 0.154 | 0.136 | Epidermal growth factor receptor kinase inhibitor | 0.136 0.058 DBMET01173 | DBMET01173 | |
| 0.019 | 0.103 | 0.211 | Purinergic P2Y2 antagonist | 0.043 0.014 DBMET01173 0.191 0.002 DBMET01174 0.211 0.001 DBMET01175 | DBMET01175 | |
| 0.038 | 0.126 | 0.086 | Heat shock protein 90 beta antagonist | 0.086 0.017 DBMET01173 | DBMET01173 | |
| 0.022 | 0.113 | 0.061 | Adenosine A1 receptor antagonist | 0.061 0.038 DBMET01173 | DBMET01173 | |
| 0.016 | 0.11 | 0.041 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET01173 0.041 0.012 DBMET01174 0.04 0.015 DBMET01175 | DBMET01174 | |
| 0.04 | 0.136 | 0.069 | ErbB-2 antagonist | 0.069 0.061 DBMET01173 | DBMET01173 | |
| 0.047 | 0.147 | 0.09 | Epidermal growth factor antagonist | 0.09 0.054 DBMET01173 | DBMET01173 | |
| 0.015 | 0.116 | 0.201 | Inosine monophosphate dehydrogenase inhibitor | 0.165 0.004 DBMET01173 0.201 0.003 DBMET01174 0.196 0.003 DBMET01175 | DBMET01174 | |
| 0.057 | 0.168 | 0.118 | EphA2 antagonist | 0.118 0.057 DBMET01173 | DBMET01173 | |
| 0.005 | 0.116 | 0.015 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET01173 0.013 0.004 DBMET01174 0.015 0.003 DBMET01175 | DBMET01175 | |
| 0.019 | 0.13 | 0.068 | Phosphatidylinositol 3-kinase delta inhibitor | 0.068 0.031 DBMET01173 | DBMET01173 | |
| 0.07 | 0.184 | 0.263 | Src kinase inhibitor | 0.263 0.033 DBMET01173 0.242 0.038 DBMET01174 0.225 0.043 DBMET01175 | DBMET01173 | |
| 0.001 | 0.143 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET01174 | DBMET01174 | |
| 0.022 | 0.185 | 0.039 | GABA B receptor antagonist | 0.039 0.037 DBMET01173 | DBMET01173 | |
| 0.049 | 0.214 | 0.096 | Phosphodiesterase 7B inhibitor | 0.096 0.062 DBMET01173 | DBMET01173 | |
| 0.04 | 0.225 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.06 DBMET01173 | DBMET01173 | |
| 0.107 | 0.304 | 0.169 | Heat shock protein 70 antagonist | 0.129 0.127 DBMET01173 0.152 0.041 DBMET01174 0.169 0.019 DBMET01175 | DBMET01175 | |
| 0.055 | 0.267 | 0.141 | EphB2 antagonist | 0.141 0.139 DBMET01173 | DBMET01173 | |
| 0.027 | 0.249 | 0.136 | Protein-tyrosine phosphatase 1B inhibitor | 0.136 0.052 DBMET01173 | DBMET01173 | |
| 0.012 | 0.234 | 0.062 | Adenosine A2 receptor antagonist | 0.062 0.047 DBMET01173 | DBMET01173 | |
| 0.039 | 0.272 | 0.125 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.125 0.078 DBMET01173 | DBMET01173 | |
| 0.035 | 0.285 | 0.11 | GABA C receptor antagonist | 0.11 0.065 DBMET01173 | DBMET01173 | |
| 0.042 | 0.294 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.164 0.066 DBMET01173 | DBMET01173 | |
| 0.003 | 0.26 | 0.026 | Adenosine kinase inhibitor | 0.019 0.017 DBMET01174 0.026 0.012 DBMET01175 | DBMET01175 | |
| 0.033 | 0.291 | 0.207 | UDP-glucose 4-epimerase inhibitor | 0.103 0.057 DBMET01173 0.161 0.025 DBMET01174 0.207 0.017 DBMET01175 | DBMET01175 | |
| 0.05 | 0.318 | 0.088 | T cell inhibitor | 0.088 0.041 DBMET01173 | DBMET01173 | |
| 0.013 | 0.296 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.016 DBMET01174 0.026 0.019 DBMET01175 | DBMET01174 | |
| 0.019 | 0.328 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.059 DBMET01173 | DBMET01173 | |
| 0.032 | 0.341 | 0.087 | Breast cancer-resistant protein inhibitor | 0.087 0.069 DBMET01173 | DBMET01173 | |
| 0.006 | 0.325 | 0.055 | Adenosine A2a receptor antagonist | 0.055 0.049 DBMET01173 | DBMET01173 | |
| 0.062 | 0.404 | 0.155 | Phospholipase C inhibitor | 0.155 0.096 DBMET01173 0.153 0.101 DBMET01174 | DBMET01173 | |
| 0.052 | 0.441 | 0.164 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.13 DBMET01173 | DBMET01173 | |
| 0.025 | 0.48 | 0.118 | Phosphodiesterase I inhibitor | 0.096 0.05 DBMET01174 0.118 0.028 DBMET01175 | DBMET01175 | |
| 0.055 | 0.518 | 0.123 | Sphingosine 1-phosphate receptor 2 agonist | 0.123 0.05 DBMET01174 0.111 0.071 DBMET01175 | DBMET01174 | |
| 0.004 | 0.539 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DBMET01174 0.029 0.023 DBMET01175 | DBMET01174 | |
| 0.027 | 0.663 | 0.253 | Hexokinase inhibitor | 0.14 0.092 DBMET01173 0.204 0.033 DBMET01174 0.253 0.017 DBMET01175 | DBMET01175 | |
| 0.016 | 0.693 | 0.119 | Insulin secretagoues | 0.119 0.113 DBMET01175 | DBMET01175 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |